AstraZeneca
AZN
#47
Rank
$279.60 B
Marketcap
$90.18
Share price
0.17%
Change (1 day)
34.30%
Change (1 year)

P/S ratio for AstraZeneca (AZN)

P/S ratio as of December 2025 (TTM): 4.81

According to AstraZeneca's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.08. At the end of 2025 the company had a P/S ratio of 4.06.

P/S ratio history for AstraZeneca from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20254.066.74%
20243.80-16.63%
20234.56-3.93%
20224.74-2.19%
20214.85-1.45%
20204.92-8.31%
20195.3725.56%
20184.2710.21%
20173.8829.36%
20163.00-14.32%
20153.503.59%
20143.3817.2%
20132.8837.53%
20122.1017.67%
20111.78-8.96%
20101.96-5.78%
20092.0810.47%
20081.88-10.96%
20072.11-31.88%
20063.10-4.92%
20053.2616.72%
20042.79-35.74%
20034.3527.15%
20023.42-1.11%
20013.46

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Bristol-Myers Squibb
BMY
2.21-54.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
2.36-51.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
3.88-19.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
2.31-52.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
2.54-47.12%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
15.2 216.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
5.28 9.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
4.97 3.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
2.64-45.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
4.50-6.48%๐Ÿ‡จ๐Ÿ‡ญ Switzerland